Raj Suryanarayanan

Oct 3, 2024 | dx.doi.org | Rahul Lalge |Raj Suryanarayanan

Jan 31, 2024 | dx.doi.org | Jinghan Li |Bhushan Munjal |Raj Suryanarayanan |Chaowang Zeng

Download Hi-Res ImageDownload to MS-PowerPointCite This:Mol. Pharmaceutics 2024, XXXX, XXX Terms & Conditions Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses).

Dec 8, 2023 | dx.doi.org | Deepika Sarin |Raj Suryanarayanan |Kunal Krishna |M. Reza Nejadnik

Biopharmaceutical products have revolutionized healthcare and have emerged as more effective (than the conventional small molecule-based pharmaceutical products) therapies for management of complex and otherwise difficult to manage diseases, including cancer, arthritis, and autoimmune disorders.

Jun 26, 2023 | pubmed.ncbi.nlm.nih.gov | Raj Suryanarayanan

Jun 26, 2023 | dx.doi.org | Raj Suryanarayanan